These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8242578)

  • 41. Radioimmunolocalization of human malignant tumors with In-111 labeled monoclonal antibody.
    Han B; Liu CG; Fang YX; Yuan M; Jiang YY; Tian JH; Wu CC; Wu YH; Liu YF
    Chin Med J (Engl); 1991 Dec; 104(12):999-1004. PubMed ID: 1782819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate cancer imaging with a new monoclonal antibody: a preliminary report.
    Sanford E; Grzonka R; Heal A; Helal M; Persky L; Tyson I
    Ann Surg Oncol; 1994 Sep; 1(5):400-4. PubMed ID: 7850541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
    Markowitz A; Saleemi K; Freeman LM
    Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Capromab pendetide. A review of its use as an imaging agent in prostate cancer.
    Lamb HM; Faulds D
    Drugs Aging; 1998 Apr; 12(4):293-304. PubMed ID: 9571393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new approach to image subtraction in immunoscintigraphy: preliminary results.
    Liehn JC; Hannequin P; Nasca S; Lebrun D; Cattan A; Valeyre J
    Eur J Nucl Med; 1987; 13(8):391-6. PubMed ID: 3325290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
    Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
    Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma.
    Hladik P; Vizda J; Bedrna J; Simkovic D; Strnad L; Smejkal K; Voboril Z
    Colorectal Dis; 2001 Nov; 3(6):380-6. PubMed ID: 12790934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo behavior of 111In-labeled monoclonal anti-prostatic acid phosphatase antibody after intraprostatic and intravenous injections.
    Kairemo KJ; Rannikko S; Nordling S; Savalainen S; Ahonen A; Taavitsainen MJ; Alfthan OS
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):151-5. PubMed ID: 7632761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels.
    Vijayakumar V; Blend MJ; Johnson D; Schnobrich K; Golick J
    Clin Nucl Med; 1992 Mar; 17(3):180-4. PubMed ID: 1611787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
    Lamki LM; Murray JL; Rosenblum MG; Patt YZ; Babaian R; Unger MW
    Nucl Med Commun; 1988 Aug; 9(8):553-64. PubMed ID: 3173914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4.
    Maeda M; Shoji M; Kawagoshi T; Futatsuya R; Honda T; Brady LW
    Cancer; 1994 Feb; 73(3 Suppl):800-7. PubMed ID: 8306263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma.
    Weiner GJ; Kahn D; Jochimsen PR; Bevering CG; Kisker MA
    Cancer Invest; 1994; 12(2):111-20. PubMed ID: 8131088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of radioimmunoscintigraphy and computed tomography scan prior to reassessment laparotomy of patients with ovarian carcinoma. A preliminary report.
    Method MW; Serafini AN; Averette HE; Rodriguez M; Penalver MA; Sevin BU
    Cancer; 1996 Jun; 77(11):2286-93. PubMed ID: 8635097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer.
    Divgi CR
    Oncology (Williston Park); 1996 Jun; 10(6):939-53; discussion 954, 957-8. PubMed ID: 8823804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radioimmunoscintigraphy in patients with ovarian cancer.
    Kalofonos HP; Karamouzis MV; Epenetos AA
    Acta Oncol; 2001; 40(5):549-57. PubMed ID: 11669325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
    Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gamma probe location of 111indium-labeled B72.3: an extension of immunoscintigraphy.
    Krag DN; Haseman MK; Ford P; Smith L; Taylor MH; Schneider P; Goodnight JE
    J Surg Oncol; 1992 Dec; 51(4):226-30. PubMed ID: 1434652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and role of repeated administrations of Indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE 025 in the postoperative follow-up of colorectal carcinoma patients.
    Abdel-Nabi HH; Doerr RJ; Chan HW; Farrell E; Evans NH; Spaulding MB; Schweighardt S; Merchant EB
    J Nucl Med; 1992 Jan; 33(1):14-22. PubMed ID: 1730980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The radioimmunoguided surgery (RIGS) system as a diagnostic tool.
    Bakalakos EA; Burak WE
    Surg Oncol Clin N Am; 1999 Jan; 8(1):129-44. PubMed ID: 9824365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress in SPECT/CT imaging of prostate cancer.
    Seo Y; Franc BL; Hawkins RA; Wong KH; Hasegawa BH
    Technol Cancer Res Treat; 2006 Aug; 5(4):329-36. PubMed ID: 16866563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.